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Introduction
Radical hysterectomy with lymphadenectomy was consid-
ered the standard surgical treatment for early-stage cervical 
cancer for over 100 years [1]. Over the past 20 years, surgical 
practice shifted from the traditional abdominal approach to 
minimally invasive surgery. With regard to the surgical out-
comes of minimally invasive surgery, various studies directed 
by multiple institutions showed that minimally invasive sur-
gery was associated with reduced blood loss, shorter hospital 
stays, and fewer postoperative complications compared to 
open surgery [2-6].
Nevertheless, survival outcomes of radical hysterectomy 
were inconsistent in recent studies. Several retrospective 
studies demonstrated that disease-free survival of minimally 
invasive radical hysterectomy and open radical hysterec-
tomy was comparable [7-11]. However, in a clinical trial for 
Laparoscopic Approach to Cervical Cancer, Ramirez et al. [12] 
reported that the survival rates of minimally invasive radical 
hysterectomy were lower than those of open radical hysterec-
tomy in cervical cancer. 
Several reports have measured surgeon’s proficiency, des-
ignated as learning curve, in terms operation time [13-15] but 
there is little report measuring learning curve of minimally 
invasive radical hysterectomy with regard to survival out-
comes. Therefore, we design the study on the learning curve 
of open radical hysterectomy and minimally invasive radical 
hysterectomy in terms of recurrence rates. In addition, tumor 
size is a well-known important survival and prognostic factor 
of cervical cancer. In the modified International Federation 
of Gynecology and Obstetrics (FIGO) staging (2018), IB stage 
was further divided with every 2 cm increase in size into IB1 
(< 2 cm), IB2 (2-3.9 cm), and IB3 (≥ 4 cm). 
These findings led us to reevaluate the impact of opera-
tion mode and tumor size on patients with cervical cancer 
treated by radical hysterectomy. Hence, in this single-center 
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Purpose  The objective of this study was to define the learning curve required to attain satisfactory oncologic outcomes of cervical 
cancer patients who were undergoing open or minimally invasive surgery for radical hysterectomy, and to analyze the correlation 
between the learning curve and tumor size.  
Materials and Methods  Cervical cancer patients (stage IA-IIA) who underwent open radical hysterectomy (n=280) or minimal inva-
sive radical hysterectomy (n=282) were retrospectively reviewed. The learning curve was evaluated using cumulative sum of 5-year 
recurrence rates. Survival outcomes were analyzed based on the operation period (“learning period,” P1 vs. “skilled period,” P2), 
operation mode, and tumor size.  
Results  The 5-year disease-free and overall survival rates between open and minimally invasive groups were 91.8% and 89.0% 
(p=0.098) and 96.1% and 97.2% (p=0.944), respectively. The number of surgeries for learning period was 30 and 60 in open and 
minimally invasive group, respectively. P2 had better 5-year disease-free survival than P1 after adjusting for risk factors (hazard ratio, 
0.392; 95% confidence interval, 0.210 to 0.734; p=0.003). All patients with tumors < 2 cm had similar 5-year disease-free survival 
regardless of operation mode or learning curve. Minimally invasive group presented lower survival rates than open group when 
tumors ≥ 2 cm in P2. Preoperative conization improved disease-free survival in patients with tumors ≥ 2 cm, especially in minimally 
invasive group. 
Conclusion  Minimally invasive radical hysterectomy required more cases than open group to achieve acceptable 5-year disease-free 
survival. When tumors ≥ 2 cm, the surgeon’s proficiency affected survival outcomes in both groups.   
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retrospective study with a large number of patients and long 
follow-up durations, we compared the survival outcomes of 
patients with early-stage cervical cancer undergoing mini-
mally invasive or open radical hysterectomy and further ana-
lyzed the effects of learning curve and tumor size on survival 
outcomes.  
Materials and Methods
1. Study population and data collection  
In this study, the records of patients with stage IA-IIA 
cervical cancer between 2002 and 2018 were retrospectively 
reviewed. Exclusion criteria were as follows: (1) underwent 
trachelectomy, type I hysterectomy or underwent only both 
pelvic lymph node dissection; (2) received neoadjuvant 
chemotherapy; (3) FIGO stage IA1 without lympho-vascu-
lar space invasion (S1 Fig.). In total, 562 patients were eligi-
ble for analysis. All the procedures were performed by six 
gynecological oncologists. A period of time before and after 
reaching the learning curve was defined as P1 (learning per- 
iod) and P2 (skilled period). All the surgeons began with 
open surgery and gradually switched to minimally invasive 
surgery as experience accumulated. All minimally invasive 
radical hysterectomy was consecutively collected from the 
first case of each physician. Surgical procedures included 
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Table 1.  Characteristics of early-stage cervical cancer patients (n=562) 
Characteristic
 Open surgery  Minimally invasive 
p-value
 (n=280) surgery (n=282)
Age, median (range, yr) 48 (18-81) 47 (22-75) 0.427
Body mass index (kg/m2)   
    < 24 174 (62.1) 185 (65.6) 0.393
    ≥ 24 106 (37.9) 97 (34.4) 
Invasion depth (cm)   
    ≤ 1  201 (71.8) 226 (80.1) 0.020
    > 1  79 (28.1) 56 (19.9) 
Tumor size (cm)   
    < 2  113 (40.4) 136 (48.2) 0.062
    ≥ 2  167 (59.6) 146 (51.8) 
Histologic type   
    Squamous cell 192 (68.6) 176 (62.4) 0.336
    Adenocarcinoma 69 (24.6) 89 (31.6) 
    Adenosquamous 13 (4.6) 11 (3.9) 
    Others 6 (2.1) 6 (2.1) 
FIGO stage    
    IA 28 (10.0) 27 (9.6) 0.005
    IB1 190 (67.9) 221 (78.4) 
    IB2-IIA 62 (22.1) 34 (12.1) 
Lympho-vascular space invasion 185 (66.1) 97 (34.4) 0.122
Resection margin involvement 21 (7.5) 12 (4.3) 0.102
Dissected lymph node number, mean±SD   
    Pelvic LN 23±10 16±10 < 0.001
    Para-aortic LN 2±3 1±4 < 0.001
    Lymph node metastasis 44 (15.7) 18 (6.4) < 0.001
Postoperative adjuvant treatment   
    No 165 (58.9) 210 (74.5) < 0.001
    Yes  115 (41.1) 72 (25.5) 
Operation type   
    Type Ⅱ radical hysterectomy 26 (9.3) 19 (6.7) 0.281
    Type Ⅲ radical hysterectomy 254 (90.7) 263 (93.3) 
Parametrial involvement 10 (3.6) 6 (2.1) 0.323
Values are presented as number (%) unless otherwise indicated. FIGO, International Federation of Gynecology and Obstetrics Clinical 
Staging of Cervical Carcinoma; LN, lymph node; SD, standard deviation.
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radical hysterectomy and pelvic lymphadenectomy. Col-
potomy was done intracorporeally in all patients. Para-aortic 
lymphadenectomy or bilateral salpingo-oophorectomy was 
performed on the basis of patients’ individual factors. The 
tumor size was sum of the greatest measured diameter of 
cone biopsy and the gross size measured via magnetic reso-
nance imaging after biopsy. Tumor size by magnetic reso-
nance imaging was determined by the greater length. Other 
histologic types included small cell carcinoma, neuroendo-
crine carcinoma, and adenosarcoma. Recurrence of cancer 
was confirmed by clinical findings, radiological examina-
tions, and pathology reports in both groups. The two groups 
have the same frequency of surveillance. The survival period 
was measured from the date of surgery to the recurrence of 
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Fig. 1.  Kaplan-Meier estimates of overall survival (A, D) and disease-free survival (B, C, E, F) for cervical cancer patients treated with open 
radical hysterectomy (ORH) and minimally invasive surgery-radical hysterectomy (MIS-RH). (A) The 5-year overall survival of open and 
minimally invasive groups were 96.1% (269/280) and 97.2% (274/282), respectively, p=0.944. (B) The 5-year disease-free survival of open 
and minimally invasive groups were 91.8% (257/280) and 89.0% (251/282), respectively, p=0.098. (C, D) P1 phase presented significantly 
worse survival rates than P2 phase in the open group (disease-free survival: 85.4% vs. 94.4%, p=0.011; overall survival: 84.1% vs. 97.5%, 
p=0.001). However, the minimally invasive group did not show statistically significant difference in survival rates of P1 and P2 phase 
(disease-free survival: 86.0% vs. 92.7%, p=0.233; overall survival: 94.8% vs. 99.1%, p=0.194). Also, there was no significant difference in 
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the disease, the last follow-up date, or death. 
2. Statistical analysis
Chi-square test was used to compare categorical variables. 
Mann-Whitney test was used for nonparametric data. Sur-
vival curves were generated using the Kaplan-Meier method 
and analyzed with log-rank test. Univariate and multivariate 
analyses were performed using Cox proportional hazards 
model. Hazard ratios (HR) greater than 1.0 implied increased 
likelihood of recurrence or death. The learning curve was 
evaluated by 5-year recurrence number using the cumula-
tive sum method [16]. The cumulative sum method of recur-
rence number for every 10th procedure is defined as Σ(Xt–X0), 
(t=10, 20, 30…), where X0 was the mean recurrence number 
for all the cases, Xt was value for each 10 cases recurrence 
number. The number of recurrences per 10 cases shown in 
the chart was the average number of recurrences per 10 cases 
by all surgeons. 
 All statistical analyses were performed using SPSS Statis-
tics ver. 25 (IBM Corp., Armonk, NY). Two-sided significant 
p-value less than 0.05 was regarded as statistically signifi-
cant.
Results
1. Characteristics and surgical outcomes
Of the 562 selected patients, traditional open surgeries 
(n=280) were performed from January 2002 to June 2018, and 
minimal invasive surgeries (laparoscopic radical hysterec-
tomy, n=127 and robotic radical hysterectomy, n=155) from 
January 2006 to June 2018. The proportions of type III were 
254 (90.7%) and 263 (93.3%) in the open and minimally inva-
sive groups. Patient characteristics of age, body mass index, 
tumor size, lympho-vascular space invasion, resection mar-
gin involvement, and histologic type were not significantly 
different between the open and minimal invasive radical 
hysterectomy groups (Table 1). Deep cervical stromal inva-
sion, higher FIGO stage, lymph node metastasis, and post-
operative adjuvant treatment were more frequent in the open 
group. 
2. Total survival outcomes of open and minimally invasive 
radical hysterectomy 
In total, we observed 18 deaths and 23 recurrences over 
a median follow-up of 10.1 years in the open group, and 10 
deaths and 32 recurrences over a median follow-up of 4.2 
years in the minimally invasive group. With regard to overall 
survival, statistically significant difference was not observed 
(Fig. 1A). The 5-year overall survival was 96.1% (269/280) in 
open group and 97.2% (274/282) in minimally invasive group 
(p=0.944). With regard to disease-free survival, there was 
no significant difference between the two groups (Fig. 1B). 
The 5-year disease-free survival rates were 91.8% (257/280) 
in the open group and 89.0% (251/282) in the minimally in-
vasive group (p=0.098). The cumulative sum learning curve 
Cancer Res Treat. 2021;53(1):243-251
Fig. 1.  (Continued from the previous page) (E) In the subgroup of patients with tumors < 2 cm, operation period or mode had little effect on 
disease-free survival. (F) In the subgroup of patient with ≥ 2 cm, P1 phase presented significantly worse disease-free survival than P2 phase 
in the open group (74.4% [32/43] vs. 91.1% [112/123], p=0.003). The minimally invasive group showed the same tendency but it was not 
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showed that 5-year recurrence numbers were significantly 
decreased at a turning point of 30 cases in the open group, 
and 60 cases in the minimally invasive group (Fig. 2). Open 
and minimally invasive groups were further divided into two 
cohorts by surgeon proficiency. (P1, 0-30 cases of open group 
or 0-60 cases of minimally invasive groups; P2, > 30 cases 
of open group or > 60 cases of minimally invasive group). 
Cox proportional univariate analysis of 5-year disease-free 
survival showed significant differences in terms of invasion 
depth, initial tumor size, histologic type, lympho-vascular 
space invasion, FIGO stage, learning curve, and postopera-
tive adjuvant treatment (S2 Table). In the multivariate analy-
sis of 5-year disease-free survival, the P2 group had lower 
risk of recurrence than P1 group after adjusting for invasion 
depth, tumor size, histologic type, lympho-vascular space 
invasion, and operation mode (HR, 0.392; 95% confidence 
interval [CI], 0.210 to 0.734; p=0.003) (Table 2). Initial tumor 
size also had a significant effect on disease-free survival in 
multivariate analysis (HR, 15.242; 95% CI, 4.644 to 50.027; 
p < 0.001). Cox proportional univariate analysis for overall 
survival was showed in S3 Table. 
3. Survival outcomes and surgeon proficiency
Except for invasion depth and postoperative adjuvant 
treatment, there was no significant difference in clinical char-
acteristics between the two groups in P1 and P2 phases (S4 
Table). Median follow-up duration was 8.1 and 5.6 years in 
P1 and P2, respectively. 
The survival rates of P1 were significantly lower than 
those of P2 phase in open group (disease-free survival, 85.4% 
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Fig. 2.  Learning curve analysis with regard to 5-year recurrence 
number. Cumulative sum for 5-year recurrence number of every 
10 cases was plotted. The 5-year recurrence number decreased 
after 30 cases in open group, and after 60 cases in the minimally 
invasive group. LRH, laparoscopic radical hysterectomy; MIS-
RH, minimally invasive surgery-radical hysterectomy; ORH, 


























Table 2.  Multivariate Cox regression analysis for 5-year disease-free survival
Variable Total (n= 562) HR (95% CI) p-value
Invasion depth (cm)
    ≤ 1 427 1 (reference) 0.948
    > 1 135 0.981 (0.549-1.753) 
Tumor size (cm)   
    < 2 249 1 (reference) 
    ≥ 2 313 15.242 (4.644-50.027) < 0.001
Histologic type   
    Squamous cell 368 1 (reference) 
    Adenocarcinoma 158 1.605 (0.844-3.053) 0.149
    Adenosquamous    24 3.758 (1.415-9.983) 0.008
    Other type   12 8.158 (3.233-20.584) < 0.001
Lympho-vascular space invasion   
    Negative 351 1 (reference) 0.251
    Positive 211 1.404 (0.786-2.506) 
Operation mode   
    Open surgery 280 1 (reference) 0.405
    Minimally invasive surgery 282 1.292 (0.708-2.358) 
Learning curve   
    P1a) 234 1 (reference) 0.003
    P2b) 328 0.392 (0.210-0.734) 
CI, confidence interval; HR, hazard ratio. a)P1 (learning period), 0-30 cases of open radical hysterectomy (ORH) or 0-60 cases of minimally 
invasive radical hysterectomy (MIS-RH), b)P2 (skilled period), > 30 cases of ORH or > 60 cases of MIS-RH. 
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in P1 vs. 94.4% in P2, p=0.011; overall survival, 84.1% in P1 
vs. 97.5% in P2, p=0.001) (Fig. 1C and D). There was no sta-
tistical significance in minimally invasive group (disease-free 
survival: 86.0% vs. 92.7%, p=0.233; overall survival: 94.8% vs. 
99.1%, p=0.194). The disease-free survival rates of open and 
minimally invasive group were comparable both in P1 and 
P2 (P1, 85.4% vs. 86.0%; P2, 94.4% vs. 92.7%). Overall sur-
vival of minimally invasive group (94.8%) was higher than 
that of open group (84.1%) in P1 but it was not statistically 
significant. Overall survival rates of the open and minimally 
invasive group were comparable in P2 (97.5% vs. 99.1%).
The most common recurrence site in the P1 phase was the 
pelvic cavity in open group and the vagina in minimally 
invasive group. However, recurrence rates of these sites dra-
matically declined in the P2 phase (S5 Fig.).
4. Survival outcomes by tumor size
On the subgroup analysis by tumor size, we excluded IA 
stage (n=55) patients. When comparing survival rates by 
tumor size, both in the two groups, the 5-year disease-free 
survival rates decreased when tumor size increased (Table 
3). Patients with small tumor size (< 2 cm) did not show any 
difference in disease-free survival based on operation mode 
or phase (Fig. 1E). However, in patients with a tumor size 
≥ 2 cm, P1 phase presented significantly worse disease-free 
survival than P2 phase in the open group (74.4% vs. 91.1%, 
p=0.003). There was no significant difference in the minimal-
ly invasive group (77.4% vs. 86.2%, p=0.193) (Fig. 1F). 
The survival rate of minimally invasive group was slightly 
better than open group with tumor size ≥ 2 cm in P1 (77.4% 
vs. 74.4%, p=0.652). Minimally invasive group presented 
lower survival rates than open group when tumor size ≥ 2 
cm in P2 (86.2% vs. 91.1%, p=0.106). However, if the patient 
underwent preoperative conization the survival rates of two 
groups were comparable when tumor size ≥ 2 cm in P2 (94.7% 
vs. 94.6%) (S6 Table). Besides, we found that patients that 
underwent preoperative conization presented significantly 
better disease-free survival than patients without coniza-
tion in the P1 minimally invasive group (89.2% vs. 68.1%, 
p=0.027) (S6 and S7 Tables).
Discussion
Minimally invasive techniques, including robotic sur-
gery, developed rapidly because of their intraoperative and 
postoperative advantages with comparable survival out-
comes [14,17,18]. As research advances, the conclusion that 
minimally invasive surgery has a better survival outcome 
than open surgery has not changed [19]; however, in 2017, 
conflicting survival data of minimally invasive radical hys-
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terectomy began to be reported [11,20]. A number of recent 
meta-analysis studies suggested that there were no signifi-
cant differences between open and minimally invasive radi-
cal hysterectomy [21-24]. However, in the study by Ramirez 
et al., the three-year survival rates of the minimally invasive 
radical hysterectomy groups are much lower than open radi-
cal hysterectomy group. 
Our results showed there was no significant difference 
in disease-free survival between the two groups. However, 
when we divided consecutive cases into two groups (initial 
cases and late cases), we noticed that disease-free survival of 
the minimally invasive group in the late case phase was sig-
nificantly better than in initial cases. This result prompted us 
to draw the learning curve of disease-free survival in order 
to find out whether there were differences in survival out-
comes before or after reaching learning curve and standardi-
zation of the technique. Our previous study [14] on learning 
curve analysis showed that the learning curve for proficiency 
and efficiency in robot-assisted radical hysterectomy was 
28 cases. However, the proficiency of surgery in that study 
was mainly defined as short docking or console time, less 
blood loss, and fewer postoperative complication rates. To 
date, there is scarce research on learning curve analysis based 
on actual survival. Chong et al. [25] compared the learning 
period of robotic (consecutive 65 cases) and skilled period 
of laparoscopic radical hysterectomy for early-stage cervi-
cal cancer. However, the number of learning period cases 
was not determined according to the learning curve but was 
randomly included in the consecutive 65 cases. Calculating 
the learning curve of radical hysterectomy and analyzing 
survival outcomes according to the learning curve was the 
primary strength of our study.
Our results indicated that 5-year disease-free survival was 
better when the surgeon reached the learning curve. How-
ever, minimally invasive group need more cases than open 
cases (30 cases vs. 60 cases) to reach learning curve. The need 
for more cases to reach the learning curve means more recur-
rence rates during the initial period of time. Several factors 
were discussed for the higher recurrence rate of cervical can-
cer [26-28]. The most commonly mentioned factor was the 
spread of cancer during intracorporeal colpotomy. However, 
all surgeons in our study performed intracorporeal colpoto-
my during minimally invasive surgery and we did not com-
pare the survival outcomes between vaginal colpotomy and 
intracorporeal colpotomy. Normally, cervical tumor size was 
considered highly associated with vaginal vault recurrence. 
In our study, the vaginal vault was the most common recur-
rence site in the minimally invasive group. We also identi-
fied that 5-year disease-free survival rates were higher in 
the smaller-sized tumor group both in open and minimally 
invasive surgery. 
Requiring more cases to reach learning curve may cause 
unexperienced surgeons to hesitate to perform minimally 
invasive surgery on patients during this period. However, 
the minimally invasive group showed a comparable disease-
free survival rate to that of the open group in the learning 
period, even if the tumor exceeded 2 cm. This means that we 
should focus not on the mode of operation, but on reducing 
the recurrence rate during the learning period. For example, 
as our result confirmed, preoperative conization may be an 
effective way to reduce recurrence rate in minimally invasive 
radical hysterectomy. 
Our study has several limitations. First of all, as we men-
tioned previously, the type of colpotomy may be associated 
with postoperative disease-free survival. The effect of the 
uterine manipulator on the disease-free survival between 
vaginal and intracorporeal colpotomy should be analyzed. 
Secondly, the 5-year follow-up period was not complete in 
all patients. Future work with updated data is required in 
order to obtain more accurate results. Finally, the effective-
ness of preoperative conization or should be fully and sys-
tematically analyzed.
In summary, the 5-year disease-free survival rate of early-
stage cervical cancer patients improved after performing 30 
and 60 surgeries for open radical hysterectomy and mini-
mally invasive radical hysterectomy, respectively. The sur-
vival rates in patients with tumors smaller than 2 cm were 
not affected by the surgeon’s proficiency both in open and 
minimally invasive group. Survival outcomes of two groups 
with tumor size ≥ 2 cm were similar during the learning 
period, but were both better during skilled period. Special 
attention needs to be paid to decrease the number of surger-
ies required to reach learning curve, especially in patients 
with a relatively large tumor size. 
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